Early onset of liver steatosis in a Japanese girl with maturity-onset diabetes of the young type 3 (MODY3)

J Clin Res Pediatr Endocrinol. 2012 Jun;4(2):104-6. doi: 10.4274/jcrpe.584.

Abstract

Maturity-onset diabetes of the young type 3 (MODY3) is caused by heterozygous mutation in the HNF1A gene. Liver adenomatosis has been reported in MODY3 patients. The patient reported in this paper is a Japanese girl who first developed hepatomegaly, fatty liver, and hepatic dysfunction at age 5 years. Liver biopsy demonstrated steatosis and degeneration of hepatocytes. At that time, blood glucose and HbA1c levels were within normal ranges. Elevated HbA1c was noticed 4 years later, but islet cell and glutamic acid decarboxylase antibodies were not detected in the serum. Therefore, MODY3 was suspected and subsequent analysis of the HNF1A gene identified a heterozygous germline splice donor-site mutation in intron 9. MODY3 patients should be screened by non-invasive liver imaging, and careful follow-up of liver disease should be performed.

Publication types

  • Case Reports

MeSH terms

  • Child, Preschool
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / diagnosis*
  • Diabetes Mellitus, Type 2 / genetics
  • Fatty Liver / complications
  • Fatty Liver / diagnosis*
  • Female
  • Follow-Up Studies
  • Hepatocyte Nuclear Factor 1-alpha / genetics
  • Humans
  • Japan
  • Liver / metabolism
  • Liver / pathology*
  • Mutation
  • Time Factors
  • Young Adult

Substances

  • HNF1A protein, human
  • Hepatocyte Nuclear Factor 1-alpha